We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-3.43%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.78B
AUM Growth
-$185M
Cap. Flow
-$20.5M
Cap. Flow %
-0.74%
Top 10 Hldgs %
20.31%
Holding
3,133
New
26
Increased
312
Reduced
483
Closed
54

Sector Composition

Rank Sector Weight
1 Technology 18.27%
2 Consumer Discretionary 10.26%
3 Financials 9.82%
4 Industrials 9.34%
5 Healthcare 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELTX icon
2976
Elicio Therapeutics
ELTX
$80.4M
$4K ﹤0.01%
167
ERNA icon
2977
Eterna Therapeutics
ERNA
$5.16M
0
FTHM icon
2978
Fathom Holdings
FTHM
$23.1M
$4K ﹤0.01%
407
IBD icon
2979
Inspire Corporate Bond ETF
IBD
$489M
$4K ﹤0.01%
175
IMRX icon
2980
Immuneering
IMRX
$328M
$4K ﹤0.01%
634
IYM icon
2981
iShares US Basic Materials ETF
IYM
$1.02B
$4K ﹤0.01%
30
LSEA
2982
DELISTED
Landsea Homes
LSEA
$4K ﹤0.01%
471
MBIO icon
2983
Mustang Bio
MBIO
$4.59M
$4K ﹤0.01%
6
NL icon
2984
NLI Holdings
NL
$329M
$4K ﹤0.01%
532
NPCE icon
2985
Neuropace
NPCE
$496M
$4K ﹤0.01%
546
RGS icon
2986
Regis Corp
RGS
$69.3M
$4K ﹤0.01%
100
RLYB icon
2987
Rallybio
RLYB
$88.1M
$4K ﹤0.01%
69
RPID icon
2988
Rapid Micro Biosystems
RPID
$84.8M
$4K ﹤0.01%
613
SLYV icon
2989
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.08B
$4K ﹤0.01%
50
-15
-23% -$1.24K
SMMT icon
2990
Summit Therapeutics
SMMT
$12B
$4K ﹤0.01%
1,762
FTH
2991
Faeth Therapeutics
FTH
$757M
$4K ﹤0.01%
80
SPRY icon
2992
ARS Pharmaceuticals
SPRY
$601M
$4K ﹤0.01%
1,032
TPIF icon
2993
Timothy Plan International ETF
TPIF
$266M
$4K ﹤0.01%
183
VCLT icon
2994
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.75B
$4K ﹤0.01%
50
VIGL
2995
DELISTED
Vigil Neuroscience
VIGL
$4K ﹤0.01%
+500
New +$6.6K
WVE icon
2996
Wave Life Sciences
WVE
$1.03B
$4K ﹤0.01%
2,106
XLO icon
2997
Xilio Therapeutics
XLO
$59.5M
$4K ﹤0.01%
41
ZVIA icon
2998
Zevia
ZVIA
$104M
$4K ﹤0.01%
786
TECX
2999
Tectonic Therapeutic
TECX
$720M
$4K ﹤0.01%
227
SYRS
3000
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$4K ﹤0.01%
367

Similar funds

Ameritas Investment Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Ameritas Investment Partners held 3,133 positions worth $2.78B, down 6.2% from $2.97B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 2.6%. Ameritas Investment Partners opened 26 new positions and exited 54, leaving the 3,133-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Ameritas Investment Partners's largest Q1 2022 buy was Bank of America Series L: 2,589 shares worth $3.4M.
  • Ameritas Investment Partners added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2022, an estimated $3.61M increase.
  • Ameritas Investment Partners's biggest Q1 2022 reduction was Molina Healthcare, cutting an estimated $4.58M.
  • Ameritas Investment Partners fully exited CyrusOne Inc Common Stock in Q1 2022, selling an estimated $4.1M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.78B portfolio in Q1 2022.
  • Ameritas Investment Partners opened 26 new positions and closed 54 in Q1 2022.
  • Ameritas Investment Partners's portfolio value fell 6.2% quarter-over-quarter to $2.78B.

Based on Ameritas Investment Partners's 13F filing for Q1 2022, filed 13 May 2022.